[Extraordinary manifestation of a gastric carcinoma by leptomeningeal carcinomatosis and spinal metastasis].

PubWeight™: 0.76‹?›

🔗 View Article (PMID 17345022)

Published in Med Klin (Munich) on March 15, 2007

Authors

Nicola Cresto1, Alain Barth, Marlene Arnold, Rosemarie Weimann, Jürgen Gschossmann, Adrian F Ochsenbein, Christos Kolotas, Hans-Jakob Peter, Uwe Schiemann

Author Affiliations

1: Klinik für Allgemeine Innere Medizin, Inselspital, Universitätsspital Bern, Bern, Schweiz.

Articles by these authors

Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. J Clin Oncol (2010) 3.05

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res (2009) 2.39

Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. Blood (2009) 2.20

Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography. AJNR Am J Neuroradiol (2002) 2.06

Cholestasis in a patient with gallstones and a normal gamma-glutamyl transferase. Hepatology (2013) 1.98

Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am J Gastroenterol (2009) 1.96

Review of liver injury associated with dietary supplements. Liver Int (2011) 1.64

rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One (2007) 1.48

Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med (2010) 1.45

Elimination of chronic viral infection by blocking CD27 signaling. J Exp Med (2006) 1.32

Acute lower gastrointestinal hemorrhage: minimally invasive management with microcatheter embolization. J Vasc Interv Radiol (2008) 1.28

Low-grade endometrial stromal sarcoma with inferior vena cava tumor thrombus and intracardiac extension: radical resection may improve recurrence free survival. Surg Oncol (2008) 1.19

Mycobacterium bohemicum cervical lymphadenitis. Pediatr Infect Dis J (2002) 1.15

Comparative evaluation of microdiscectomy only, autograft fusion, polymethylmethacrylate interposition, and threaded titanium cage fusion for treatment of single-level cervical disc disease: a prospective randomized study in 125 patients. Neurosurg Focus (2002) 1.15

Prehospital ultrasound in emergency medicine: incidence, feasibility, indications and diagnoses. Eur J Emerg Med (2010) 1.09

Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections. Blood (2006) 1.08

Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol (2007) 1.04

Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p. Clin Cancer Res (2006) 1.03

Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL. Eur J Immunol (2005) 1.03

CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression. J Clin Invest (2012) 0.99

Multiple spinal extradural meningeal cysts presenting as acute paraplegia. Case report and review of the literature. J Neurosurg Spine (2007) 0.98

CD27 signaling increases the frequency of regulatory T cells and promotes tumor growth. Cancer Res (2012) 0.98

CD4+ T cell help improves CD8+ T cell memory by retained CD27 expression. Eur J Immunol (2008) 0.98

Endovascular treatment of posterior circulation cerebral aneurysms by using Guglielmi detachable coils: a 10-year single-center experience with special regard to technical development. AJNR Am J Neuroradiol (2005) 0.98

Decompressive craniotomy after middle cerebral artery infarction. Retrospective analysis of patients treated in three centres in Switzerland. Swiss Med Wkly (2004) 0.97

From "magic bullets" to specific cancer immunotherapy. Swiss Med Wkly (2013) 0.97

Galectin-3 modulates T cell activity and is reduced in the inflamed intestinal epithelium in IBD. Inflamm Bowel Dis (2006) 0.96

Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ. J Exp Med (2013) 0.96

CTL induction by cross-priming is restricted to immunodominant epitopes. Eur J Immunol (2009) 0.92

Risk factors promoting hypertensive crises: evidence from a longitudinal study. Am J Hypertens (2010) 0.92

CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results. Strahlenther Onkol (2007) 0.91

Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma. FEBS Lett (2007) 0.91

Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype. Inflamm Bowel Dis (2005) 0.90

rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population. Am J Gastroenterol (2009) 0.90

Use of diffusion-weighted magnetic resonance imaging in differentiating purulent brain processes from cystic brain tumors. J Neurosurg (2002) 0.90

IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. J Clin Invest (2015) 0.89

Endovascular and surgical treatment of spinal dural arteriovenous fistulas. Neuroradiology (2008) 0.89

Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies. J Thorac Oncol (2011) 0.88

A combined presentation of Graves' disease and Miller-Fisher syndrome. Lancet (2008) 0.85

Cell replacement therapy for intracerebral hemorrhage. Neurosurg Focus (2008) 0.84

Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells. Blood (2009) 0.84

Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma. Clin Sci (Lond) (2014) 0.84

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. Cancer Immunol Immunother (2014) 0.84

MDR1 gene polymorphism in ulcerative colitis. Gastroenterology (2004) 0.84

Rapid measurement of S-100B serum protein levels by Elecsys S100 immunoassay in patients undergoing carotid artery stenting or endarterectomy. Clin Biochem (2006) 0.83

A case report of Clarkson's disease: If you don't know it, you'll miss it. Eur J Intern Med (2006) 0.83

Primer extension based quantitative polymerase chain reaction reveals consistent differences in the methylation status of the MGMT promoter in diffusely infiltrating gliomas (WHO grade II-IV) of adults. J Neurooncol (2010) 0.83

The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease. Int Immunol (2007) 0.83

Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes. Inflamm Bowel Dis (2006) 0.83

3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer. Radiother Oncol (2004) 0.83

Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol (2010) 0.82

The -2518 promotor polymorphism in the MCP-1 gene is not associated with liver cirrhosis in chronic hepatitis C virus infection. Gastroenterology (2004) 0.81

Hypofractionated accelerated computed tomography-guided interstitial high-dose-rate brachytherapy for liver malignancies. Brachytherapy (2012) 0.80

Primary tumors of the submandibular glands: a retrospective study based on 41 cases. Oral Oncol (2010) 0.79

Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study. Eur Radiol (2013) 0.79

Natural antibodies target virus-antibody complexes to organized lymphoid tissue. Autoimmun Rev (2008) 0.79

Early clinical trial experience with vaccine therapies in non-small-cell lung cancer. Clin Lung Cancer (2008) 0.79

Restenosis after microsurgical non-patch carotid endarterectomy in 586 patients. Acta Neurochir (Wien) (2011) 0.78

Modulating CD27 signaling to treat cancer. Oncoimmunology (2012) 0.78

Orbital manifestation of whipple's disease: an atypical case. J Craniomaxillofac Surg (2007) 0.78

Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient. J Neurovirol (2008) 0.78

Oligodendroglioma with neurocytic differentiation and characteristic loss of heterozygosity on chromosomes 1p and 19q. Acta Neuropathol (2005) 0.78

Successful treatment of cervical esophageal perforation in Behcet's disease with drainage operation and infliximab. Am J Gastroenterol (2003) 0.78

Decreased tumor surveillance after adoptive T-cell therapy. Cancer Res (2007) 0.78

Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells. PLoS One (2011) 0.77

Chronic myelogenous leukemia maintains specific CD8(+) T cells through IL-7 signaling. Eur J Immunol (2010) 0.77

Biliary diseases in heart transplanted patients: a comparison between cyclosporine A versus tacrolimus-based immunosuppression. Eur J Med Res (2009) 0.77

Applicability and dosimetric impact of ultrasound-based preplanning in high-dose-rate brachytherapy of prostate cancer. Strahlenther Onkol (2004) 0.76

Objective response to radiation therapy and long-term survival of patients with WHO grade II astrocytic gliomas with known LOH 1p/19q status. Strahlenther Onkol (2007) 0.75

Patient selection for carotid angioplasty and stenting. Stroke (2002) 0.75

Pinealectomy affects bone mineral density and structure--an experimental study in sheep. BMC Musculoskelet Disord (2011) 0.75

Treatment-resistant lingual Crohn's disease disappears after infliximab. Scand J Gastroenterol (2005) 0.75

Interferons in hematopoiesis and leukemia. Oncoimmunology (2013) 0.75

5-ASA therapy and renal function in inflammatory bowel disease. Am J Gastroenterol (2005) 0.75

Outcome of the antibody response: a question of antigen dose and distribution. Trends Immunol (2004) 0.75

FDG uptake in metastatic spreading mucoepidermoid carcinoma of the thyroid. Clin Nucl Med (2007) 0.75

A 40-day siege. Am J Med (2009) 0.75

[Malignant lymphoma of the prostate--diagnosis on the second biopsy]. Med Klin (Munich) (2008) 0.75

Repeated laser-assisted high-flow bypass for recurrent giant intracranial aneurysm. Swiss Med Wkly (2006) 0.75

Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case. J Oral Maxillofac Surg (2010) 0.75

Papillary glioneuronal tumor. Pathol Res Pract (2006) 0.75

Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer. Strahlenther Onkol (2006) 0.75

Extraluminal gastrointestinal stromal tumour in the second portion of the duodenum. Eur J Gastroenterol Hepatol (2003) 0.75

Mixed intoxication with Aconitum nappellans (monkshood) and Digitalis grandiflora (large yellow foxglove). Med Sci Monit (2010) 0.75

[What is your diagnosis? Horner syndrome in spontaneous dissection of the internal carotid artery]. Praxis (Bern 1994) (2008) 0.75